Discounted Cash Flow Rating

Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Savara Inc. (SVRA)

Pharmaceutical Preparations

https://www.savarapharma.com

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's lead program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

6836 BEE CAVE ROAD, BUILDING 3, SUITE 201
AUSTIN, TX

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/18/1996

Market Cap

710,253,315

Shares Outstanding

135,340,000

Weighted SO

135,341,024

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

STOK --.--%

EWTX --.--%

CRNX --.--%

DYN --.--%

RVMD --.--%

IKNA --.--%

XLO --.--%

TARA --.--%

SRRK --.--%

Beta

0.9950

Last Div

0.0000

Range

3.115-5.7

Chg

-0.1950

Avg Vol

1836337

Mkt Cap

710253315

Exch

NASDAQ

Country

US

Phone

512 614 1848

DCF Diff

4.3759

DCF

-0.0009

Div Yield

0.0000

P/S

0.0000

EV Multiple

-8.8807

P/FV

7.7444

Div Yield %

0.0000

P/E

-10.4646

PEG

0.3270

Payout

0.0000

Current Ratio

11.2856

Quick Ratio

11.2856

Cash Ratio

2.1145

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

4663.7358

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0165

ROA

-0.5390

ROE

-0.5899

ROCE

-0.6336

NI/EBT

1.0000

EBT/EBIT

0.9256

EBIT/Rev

0.0000

Debt Ratio

0.1907

D/E

0.2618

LT Debt/Cap

0.2066

Total Debt/Cap

0.2075

Int Coverage

-56.3289

CF/Debt

-2.6994

Equity Multi

1.3729

Rec Turnover

0.0000

Pay Turnover

0.0783

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-0.3938

FCF/Share

-0.3943

Cash/Share

0.6655

OCF/Sales

0.0000

FCF/OCF

1.0014

CF Coverage

-2.6994

ST Coverage

-473.0395

CapEx Coverage

-733.6939

Div&CapEx Cov

-733.6939

P/BV

7.7444

P/B

7.7444

P/S

0.0000

P/E

-10.4646

P/FCF

-9.8646

P/OCF

-10.9573

P/CF

-10.9573

PEG

0.3270

P/S

0.0000

EV Multiple

-8.8807

P/FV

7.7444

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation